Influence of metastatic site as an additional predictor for response and outcome in advanced colorectal carcinoma
Authors:
Open Access
- 12 March 1999
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 79 (11-12) , 1800-1805
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin.Journal of Clinical Oncology, 1997
- Prognostic variables in patients with advanced colorectal cancer treated with fluorouracil and leucovorin-based chemotherapyMedical and Pediatric Oncology, 1996
- Continuous infusion fluorouracil/leucovorin and bolus mitomycin-C as a salvage regimen for patients with advanced colorectal cancerCancer, 1995
- Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastasesThe Lancet, 1994
- Poor prognosis associated with elevated serum CA 19-9 level in advanced colorectal carcinoma, independent of DNA ploidy or SPFEuropean Journal of Cancer, 1993
- Chemotherapy for metastatic colorectal cancerCancer, 1992
- Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project.Journal of Clinical Oncology, 1992
- Elevated CA19‐9 as the most significant prognostic factor in advanced colorectal carcinomaJournal of Surgical Oncology, 1992
- Determinants of survival in patients with unresectable colorectal liver metastasesJournal of Surgical Oncology, 1989
- Factors affecting survival in patients presenting with synchronous hepatic metastases from colorectal cancer: A clinical and computer analysisBritish Journal of Surgery, 1985